Edition:
United Kingdom

Intellia Therapeutics Inc (NTLA.OQ)

NTLA.OQ on NASDAQ Stock Exchange Global Market

16.48USD
5:30pm BST
Change (% chg)

$-0.30 (-1.79%)
Prev Close
$16.78
Open
$16.70
Day's High
$16.77
Day's Low
$16.00
Volume
77,207
Avg. Vol
220,585
52-wk High
$32.95
52-wk Low
$11.05

Select another date:

Fri, Mar 1 2019

Photo

Intellia CEO not involved in Starboard's Bristol-Myers board challenge

NEW YORK Intellia Therapeutics Inc Chief Executive John Leonard, who U.S. drug maker Bristol-Myers Squibb Co said last week was nominated by hedge fund Starboard Value LP to sit on its board, is not affiliated with the effort, an Intellia spokeswoman said on Thursday.

Intellia CEO not involved in Starboard's Bristol-Myers board challenge

NEW YORK Intellia Therapeutics Inc Chief Executive John Leonard, who U.S. drug maker Bristol-Myers Squibb Co said last week was nominated by hedge fund Starboard Value LP to sit on its board, is not affiliated with the effort, an Intellia spokeswoman said on Thursday.

CORRECTED-Intellia CEO not involved in Starboard's Bristol-Myers board challenge

NEW YORK, Feb 28 Intellia Therapeutics Inc Chief Executive John Leonard, who U.S. drug maker Bristol-Myers Squibb Co said last week was nominated by hedge fund Starboard Value LP to sit on its board, is not affiliated with the effort, an Intellia spokeswoman said on Thursday.

Select another date: